Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Keith D. Lindor; Christopher L. Bowlus; James Boyer; Cynthia Levy; Marlyn Mayo

doi:10.1002/hep.32117

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

Keith D. Lindor, Christopher L. Bowlus, James Boyer, Cynthia Levy, Marlyn Mayo

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1012-1013
Number of pages	2
Journal	Hepatology
Volume	75
Issue number	4
DOIs	https://doi.org/10.1002/hep.32117
State	Published - Apr 2022

ASJC Scopus subject areas

Hepatology

Access to Document

10.1002/hep.32117

Cite this

@article{824c7f989b2941449af1b242a75f193c,

title = "Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases",

author = "Lindor, {Keith D.} and Bowlus, {Christopher L.} and James Boyer and Cynthia Levy and Marlyn Mayo",

note = "Funding Information: The funding for the development of this practice guidance was provided by the American Association for the Study of Liver Diseases. This updated practice guidance was approved by the American Association for the Study of Liver Diseases on July 30, 2021. The authors are grateful for the valuable contributions of the American Association for the Study of Liver Diseases Practice Guideline Committee. Members of the committee include George Ioannou (chair); Rabab Ali, Scott W. Biggins, Roniel Cabrera, Henry Chang, Michael F. Chang, Albert Do, David S. Goldberg, R. W. Ray Kim (board liaison), Lindsay Y. King, Cynthia Levy, Jeff McIntyre, Jessica L. Mellinger, Anthony J. Michaels, Mindie H. Nguyen, Nadia Ovchinsky, Anjana A. Pillai, Daniel S. Pratt, Hugo R. Rosen, Christopher J. Sonnenday, Matthew J. Stotts, Lisa B. VanWagner, and Elizabeth C. Verna. Funding Information: Dr. Mayo consults for and received grants from Cymabay. She received grants from Intercept. Dr. Levy consults for, advises, and received grants from Intercept, Cymabay, Genfit, GSK, Pliant, Mirum, and Cara Therapeutics. She consults for and advises Escient, Teva, and Calliditas. She received grants from Gilead, Novartis, High Tide, Zydus, and Target PharmaSolutions. She receives royalities from Up‐to‐date.",

year = "2022",

month = apr,

doi = "10.1002/hep.32117",

language = "English (US)",

volume = "75",

pages = "1012--1013",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Primary biliary cholangitis

T2 - 2021 practice guidance update from the American Association for the Study of Liver Diseases

AU - Lindor, Keith D.

AU - Bowlus, Christopher L.

AU - Boyer, James

AU - Levy, Cynthia

AU - Mayo, Marlyn

N1 - Funding Information: The funding for the development of this practice guidance was provided by the American Association for the Study of Liver Diseases. This updated practice guidance was approved by the American Association for the Study of Liver Diseases on July 30, 2021. The authors are grateful for the valuable contributions of the American Association for the Study of Liver Diseases Practice Guideline Committee. Members of the committee include George Ioannou (chair); Rabab Ali, Scott W. Biggins, Roniel Cabrera, Henry Chang, Michael F. Chang, Albert Do, David S. Goldberg, R. W. Ray Kim (board liaison), Lindsay Y. King, Cynthia Levy, Jeff McIntyre, Jessica L. Mellinger, Anthony J. Michaels, Mindie H. Nguyen, Nadia Ovchinsky, Anjana A. Pillai, Daniel S. Pratt, Hugo R. Rosen, Christopher J. Sonnenday, Matthew J. Stotts, Lisa B. VanWagner, and Elizabeth C. Verna. Funding Information: Dr. Mayo consults for and received grants from Cymabay. She received grants from Intercept. Dr. Levy consults for, advises, and received grants from Intercept, Cymabay, Genfit, GSK, Pliant, Mirum, and Cara Therapeutics. She consults for and advises Escient, Teva, and Calliditas. She received grants from Gilead, Novartis, High Tide, Zydus, and Target PharmaSolutions. She receives royalities from Up‐to‐date.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85121426341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121426341&partnerID=8YFLogxK

U2 - 10.1002/hep.32117

DO - 10.1002/hep.32117

M3 - Comment/debate

C2 - 34431119

AN - SCOPUS:85121426341

SN - 0270-9139

VL - 75

SP - 1012

EP - 1013

JO - Hepatology

JF - Hepatology

IS - 4

ER -

Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this